Legal & General Group’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-218,935
| Closed | -$18.6M | – | 3389 |
|
|
2019
Q4 | $18.6M | Buy |
218,935
+19,294
| +10% | +$1.29M | 0.01% | 832 |
|
|
2019
Q3 | $9.98M | Buy |
199,641
+17,077
| +9% | +$681K | 0.01% | 979 |
|
|
2019
Q2 | $6.66M | Buy |
182,564
+8,294
| +5% | +$271K | ﹤0.01% | 1142 |
|
|
2019
Q1 | $4.87M | Buy |
174,270
+14,356
| +9% | +$338K | ﹤0.01% | 1194 |
|
|
2018
Q4 | $3.05M | Buy |
159,914
+5,835
| +4% | +$136K | ﹤0.01% | 1355 |
|
|
2018
Q3 | $4.6M | Buy |
154,079
+12,563
| +9% | +$473K | ﹤0.01% | 1225 |
|
|
2018
Q2 | $5.1M | Buy |
141,516
+3,334
| +2% | +$108K | ﹤0.01% | 1106 |
|
|
2018
Q1 | $4.56M | Buy |
138,182
+4,321
| +3% | +$135K | ﹤0.01% | 1141 |
|
|
2017
Q4 | $3.66M | Buy |
133,861
+4,335
| +3% | +$134K | ﹤0.01% | 1276 |
|
|
2017
Q3 | $4.79M | Sell |
129,526
-9,196
| -7% | -$339K | ﹤0.01% | 1055 |
|
|
2017
Q2 | $5.28M | Buy |
138,722
+14,092
| +11% | +$628K | ﹤0.01% | 954 |
|
|
2017
Q1 | $6.09M | Buy |
124,630
+3,724
| +3% | +$170K | 0.01% | 861 |
|
|
2016
Q4 | $4.11M | Buy |
120,906
+56,384
| +87% | +$2M | ﹤0.01% | 969 |
|
|
2016
Q3 | $2.44M | Buy |
64,522
+49,639
| +334% | +$1.87M | ﹤0.01% | 949 |
|
|
2016
Q2 | $502K | Hold |
14,883
| – | – | ﹤0.01% | 1344 |
|
|
2016
Q1 | $465K | Buy |
14,883
+1,324
| +10% | +$43.2K | ﹤0.01% | 1338 |
|
|
2015
Q4 | $505K | Buy |
13,559
+872
| +7% | +$33K | ﹤0.01% | 1326 |
|
|
2015
Q3 | $470K | Buy |
12,687
+646
| +5% | +$22.7K | ﹤0.01% | 1315 |
|
|
2015
Q2 | $347K | Buy |
12,041
+563
| +5% | +$15.7K | ﹤0.01% | 1471 |
|
|
2015
Q1 | $324K | Buy |
11,478
+1,795
| +19% | +$50.4K | ﹤0.01% | 1442 |
|
|
2014
Q4 | $259K | Hold |
9,683
| – | – | ﹤0.01% | 1452 |
|
|
2014
Q3 | $223K | Buy |
+9,683
| New | +$246K | ﹤0.01% | 1459 |
|
Other funds holding MDCO
Legal & General Group's MDCO Position: Q1 2020 in Review
Legal & General Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 218,935 shares — an estimated $18.6M sold.
Legal & General Group first reported a position in MDCO in Q3 2014 and held it in 22 quarters. The position peaked at $18.6M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Legal & General Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Legal & General Group sold 218,935 Medicines Co shares in Q1 2020, an estimated $18.6M.
- Legal & General Group first reported a position in Medicines Co in Q3 2014 and held it in 22 quarters.
- Legal & General Group's Medicines Co position peaked at $18.6M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Legal & General Group's 13F filing for Q1 2020, filed 14 May 2020.